The association of total pulses with the efficacy of repetitive transcranial magnetic stimulation for treatment-resistant major depression : A dose-response meta-analysis

Copyright © 2024 Elsevier B.V. All rights reserved..

AIM: This study aimed to examine dose-effects of total pulses on improvement of depressive symptoms in patients with treatment-resistant depression (TRD) receiving repetitive transcranial magnetic stimulation (rTMS) over the left dorsal lateral prefrontal cortex (DLPFC).

MATERIALS AND METHODS: The MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, PsycINFO, and ClinicalTrial.gov databases were systematically searched. We included randomized, double-blind, placebo-controlled trials (RCT) that used rTMS over left DLPFC in patients with TRD. Excluded studies were non-TRD, non-RCTs, or combined other brain stimulation interventions. The outcome of interest was the difference between rTMS arms and sham controls in improvement of depressive symptoms in a dose-response manner. A random-effects meta-analysis and dose-response meta-analysis(DRMA) was used to examine antidepressant efficacy of rTMS and association with total pulses.

RESULTS: We found that rTMS over left DLPFC is superior to sham controls (reported as standardized mean difference[SMD] with 95% confidence interval: 0.77; 0.56-0.98). The best-fitting model of DRMA was bell-shaped (estimated using restricted cubic spline model; R2 =0.42), indicating that higher doses (>26,660 total pulses) were not associated with increased improvement of depressive symptoms. Stimulation frequency(R2 =0.53) and age(R2 =0.51) were significant moderators for the dose-response curve. Furthermore, 15-20 Hz rTMS was superior to 10 Hz rTMS (0.61, 0.15-1.10) when combining all doses.

CONCLUSIONS: Our findings suggest higher doses(total pulses) of rTMS were not always associated with increased improvement of depressive symptoms in patients with TRD, and that the dose-response relationship was moderated by stimulation frequency and age. These associations emphasize the importance of determining dosing parameters to achieve maximum efficacy.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:92

Enthalten in:

Asian journal of psychiatry - 92(2024) vom: 09. Feb., Seite 103891

Sprache:

Englisch

Beteiligte Personen:

Yu, Chia-Ling [VerfasserIn]
Kao, Yu-Chen [VerfasserIn]
Thompson, Trevor [VerfasserIn]
Brunoni, Andre R [VerfasserIn]
Hsu, Chih-Wei [VerfasserIn]
Carvalho, Andre F [VerfasserIn]
Chu, Che-Sheng [VerfasserIn]
Tseng, Ping-Tao [VerfasserIn]
Tu, Yu-Kang [VerfasserIn]
Yang, Fu-Chi [VerfasserIn]
Su, Kuan-Pin [VerfasserIn]
Cheng, Shu-Li [VerfasserIn]
Hsu, Tien-Wei [VerfasserIn]
Liang, Chih-Sung [VerfasserIn]

Links:

Volltext

Themen:

Antidepressive Agents
Dose-response meta-analysis
High-frequency repetitive transcranial magnetic stimulation
Journal Article
Meta-Analysis
Review
Stimulation frequency
Systematic Review
Total pulses
Treatment-resistant depression

Anmerkungen:

Date Completed 14.02.2024

Date Revised 14.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ajp.2023.103891

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366743570